ECMO, Severe Lung Failure
Hospital to Home: Walking and Talking with Abiomed Breethe OXY-1 System™
Bart Griffith, MD, presents and leads a panel discussion on clinical experience with the Abiomed Breethe OXY-1 System™. The presentation, titled “Hospital to Home: Walking and Talking on ECMO,” was an Abiomed-sponsored session at the 2021 ISHLT Annual Meeting and Scientific Sessions. The session covers the vision for extending ECMO beyond the ICU and the development of the Abiomed Breethe OXY-1 System. Dr. Griffith and the panelists discuss the importance of patient ambulation, the small footprint of the Abiomed Breethe OXY-1 System in the ICU, and various aspects of the system design.
Dr. Griffith begins by stating that the Abiomed Breethe OXY-1 System™, which was recently introduced clinically after 20 years of development at the University of Maryland, “is designed unlike any other system that we use today, and I think it’s an important, perhaps next step to freeing patients from hospital bed and beyond.”
Dr. Griffith discusses the current Abiomed Breethe OXY-1 System patient clinical experience as of March 25, 2021. He then describes the Breethe OXY-1 System system, highlighting that it is designed for mobility with a compact console with wheels and a handle and a built-in oxygen concentrator capable of delivering 3 liters of continuous oxygen flow per minute and supporting transition from bed to ambulation.
“It’s an easy and intuitive system to use,” Dr. Griffith emphasizes. “Our nurses like it. Our nurse practitioners like it. And our physical therapists like it… Unlike some of the more complicated systems, where there’s all kinds of sensors and pressure monitors, we built this thing to go overland and it’s pretty simple.”